Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Morphosys ag symbols : Nvsef save search
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.32%
H: 0.48%
C: -0.17%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
for novartis
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
acquisition clearance novartis
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published: 2024-02-05 (Crawled : 22:00) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: -1.56%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.15%
H: 0.6%
C: 0.42%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 1.39%
H: 0.34%
C: -7.08%
pipeline acquire novartis agreement
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -1.09%
H: 1.03%
C: 0.91%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 2.22%
H: 0.6%
C: -9.4%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -0.28%
H: 1.0%
C: -0.46%
presentation meeting
Incyte Announces Data from Across its Oncology Portfolio will be Presented at the AACR Annual Meeting 2023
Published: 2023-03-14 (Crawled : 01:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 1.2%
H: 0.17%
C: -1.67%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: -1.79%
H: 3.39%
C: 3.39%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.18%
H: 1.06%
C: 0.94%
meeting
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published: 2022-05-26 (Crawled : 11:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 3.5%
H: 2.14%
C: 0.19%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: -1.13%
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $18.03 0.45% 0.44% 400K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.